Every SPAC announcement, as it is filed

Press releases are filed as exhibits to Form 8-K. Each one here has been read out of the filing, classified by what it announces, and attached to the SPAC that issued it.

• 3 September 2026PlusAI, a Leader in Physical AI Pioneering AI-Based Virtual Driver Software For Factory-Built Autonomous Trucks, to Become Publicly Listed Through Business Combination with Texas Ventures Acquisition III CorpDeal announced · Texas Ventures Acquisition III Corp
• 2 September 2026Exhibit 99.1  HECATE ENERGY AND EGH ACQUISITON CORP. PROVIDE UPDATE ON PATH TO PLANNED NASDAQ LISTING AND PROGRESS TOWARD BUSINESS COMBINATIONDeal announced · EGH Acquisition Corp.
• 1 September 2026Exhibit 99.1 ELECTRA AI Selected by Mooving to Power Battery Intelligence Across Its Battery-Swapping Network ELECTRA AI Brain for Batteries™ platform will power battery monitoring and optimization across Mooving'sOther · Iron Horse Acquisition II Corp.
• 31 August 2026Exhibit 99.1 NorthStrive Acquisition Corp I. Announces the Separate Trading of its Class A Ordinary Shares, Rights and Warrants, Commencing September 2, 2026Separate trading · NorthStrive Acquisition Corp I.
• 31 August 2026Exhibit 99.1 Samos Energy Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 31, 2026Separate trading · Samos Energy Acquisition Corp
• 4 December 2024Exhibit 99.1 FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress TowardsListing & compliance · FutureTech II Acquisition Corp.
• 20 September 2024EXHIBIT 99.1 Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human HealthDeal announced · FutureTech II Acquisition Corp.
• 17 May 2023Exhibit 99.1 FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business CombinationExtension · FutureTech II Acquisition Corp.
• 23 February 2023Exhibit 99.1 Warburg Pincus Capital Corporation I-A will redeem its Public Shares and will not consummate an initial business combinationCombination closed · Warburg Pincus Capital Corp I-A
• 21 February 2023Exhibit 99.1 FutureTech II Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business CombinationCombination closed · FutureTech II Acquisition Corp.
• 27 December 2022Exhibit 99.1  Disc Medicine Receives FDA Orphan Drug Designation for Bitopertin for the Treatment of Erythropoietic ProtoporphyriaOther · Disc Medicine, Inc.
• 13 December 2022Exhibit 99.1  Disc Medicine Announces Several Presentations Across Hematology Portfolio at the 64th American Society of Hematology Annual MeetingOther · Disc Medicine, Inc.
• 29 November 2022Exhibit 99.1 FOXWAYNE ENTERPRISES ACQUISITION CORP. ANNOUNCES CHANGE OF SPECIAL MEETING DATE AND INCREASE IN ITS CONTRIBUTION TO THE TRUST ACCOUNT FOR EXTENSION PROPOSALExtension · FoxWayne Enterprises Acquisition Corp.
• 20 September 2022Exhibit 99.1  Live Streaming Social Entertainment Platform Powering the Creator Economy, Clover Inc., to Merge with Special Purpose Acquisition Company, FoxWayne Enterprises Acquisition Corp., toOther · FoxWayne Enterprises Acquisition Corp.
• 10 August 2022Exhibit 99.4  Arix Bioscience plc Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini TherapeuticsDeal announced · Disc Medicine, Inc.
• 10 August 2022Exhibit 99.1 Gemini Therapeutics and Disc Medicine Announce Merger AgreementDeal announced · Disc Medicine, Inc.
• 8 April 2022Exhibit 99.1 FutureTech II Acquisition Corp. Announces** **the Separate Trading of its Class A Common Stock and WarrantsSeparate trading · FutureTech II Acquisition Corp.
• 10 March 2022Exhibit 99.1  Gemini Therapeutics Reports 2021 Financial ResultsOther · Disc Medicine, Inc.
• 4 March 2022Exhibit 99.1 Aerami Therapeutics Holdings, Inc. and FoxWayne Enterprises Acquisition Corp. Mutually Agree to Terminate Business Combination AgreementTermination · FoxWayne Enterprises Acquisition Corp.
• 28 February 2022Exhibit 99.1  Gemini Therapeutics Provides Corporate UpdateOther · Disc Medicine, Inc.
• 24 February 2022Exhibit 99.2 FutureTech II Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment OptionIPO closing · FutureTech II Acquisition Corp.
• 24 February 2022Exhibit 99.1 FutureTech II Acquisition Corp. Announces Pricing of $100,000,000 Initial Public OfferingIPO pricing · FutureTech II Acquisition Corp.
• 10 January 2022Exhibit 99.1  Gemini Therapeutics Provides GEM103 Program UpdateOther · Disc Medicine, Inc.
• 15 November 2021Exhibit 99.1  Gemini Therapeutics Reports Third Quarter 2021 Financial ResultsOther · Disc Medicine, Inc.
• 12 November 2021Exhibit 99.1  Gemini Therapeutics Announces Poster Presentation at AAO 2021Other · Disc Medicine, Inc.
• 6 October 2021Exhibit 99.1  Gemini Therapeutics Announces Corporate Restructuring to Prioritize Late-Stage Clinical Development of GEM103 for Geographic AtrophyOther · Disc Medicine, Inc.
• 12 August 2021Exhibit 99.1  Gemini Therapeutics Reports Second Quarter 2021 Financial ResultsOther · Disc Medicine, Inc.
• 29 June 2021Exhibit 99.1 Falcon Capital Shareholders Approve Business Combination with Sharecare, Inc.Shareholder vote · Sharecare, Inc.
• 23 June 2021Exhibit 99.1  Gemini Therapeutics Announces Initial Data from its Ongoing Phase 2a Study of GEM103 inOther · Disc Medicine, Inc.
• 3 June 2021Exhibit 99.1 Falcon Capital Announces Effectiveness of Registration Statement forRegistration statement · Sharecare, Inc.
• 1 June 2021Exhibit 99.1  Sharecare provides update on first quarter 2021 financial results and operational highlightsOther · Sharecare, Inc.
• 26 May 2021Exhibit 99.1  Sharecare CEO Jeff Arnold to speak at Goldman Sachs 42nd Annual Global Healthcare ConferenceOther · Sharecare, Inc.
• 13 May 2021Exhibit 99.1  Gemini Therapeutics Reports First Quarter 2021 Financial Results and Provides Business UpdateOther · Disc Medicine, Inc.
• 23 April 2021Exhibit 99.1 Warburg Pincus Capital Corporation I-A Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing April 26, 2021Separate trading · Warburg Pincus Capital Corp I-A
• 14 April 2021Exhibit 99.1  Gemini Therapeutics Appoints Samuel Barone, M.D., as Chief Medical OfficerOther · Disc Medicine, Inc.
• 29 March 2021Exhibit 99.1  Gemini Therapeutics Reports Full Year 2020 Financial Results and Provides Business UpdateOther · Disc Medicine, Inc.
• 3 March 2021Exhibit 99.1  WELLSTAR HEALTH SYSTEM AND SHARECARE ENTER PARTNERSHIP TO DELIVER INNOVATIVE, PERSONALIZED HEALTH AND WELLNESS PLATFORM FOR TEAM MEMBERS AND CONSUMERSOther · Sharecare, Inc.
• 25 February 2021Exhibit 99.1  FoxWayne Enterprises Acquisition Corp. Announces Securities to Commence Separate TradingSeparate trading · FoxWayne Enterprises Acquisition Corp.
• 23 February 2021Exhibit 99.1 Sharecare completes acquisition of doc.ai, enhancing digital health offering with innovative AI solutions and tech capabilitiesOther · Sharecare, Inc.
• 19 February 2021Exhibit 99.1 |  |  | | --- | --- | Sharecare and Digital Alpha announce a strategic collaboration to strengthen the nexus of healthcare and digital infrastructure across AmericaOther · Sharecare, Inc.
• 12 February 2021Exhibit 99.1 Sharecare and Falcon Capital Acquisition Corp. Reach Agreement to Combine, Creating Publicly Traded Digital Health CompanyDeal announced · Sharecare, Inc.
• 11 February 2021Exhibit 99.2  Gemini Therapeutics Debuts as Publicly Traded Precision Medicine Company Focused on Age-Related Macular DegenerationOther · Disc Medicine, Inc.
• 22 January 2021Exhibit 99.2  FoxWayne Enterprises Acquisition Corp. Announces Closing of $57,500,000 Initial Public Offering Including Full Exercise of the Underwriters' Over-Allotment OptionIPO closing · FoxWayne Enterprises Acquisition Corp.
• 22 January 2021Exhibit 99.1  FoxWayne Enterprises Acquisition Corp. Announces Pricing of $50,000,000 Initial Public OfferingIPO pricing · FoxWayne Enterprises Acquisition Corp.
• 19 January 2021Exhibit 99.1 FS Development Corp. Announces Effectiveness of Registration Statement forRegistration statement · Disc Medicine, Inc.
• 9 November 2020Exhibit 99.1 Falcon Capital Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing on or About November 12, 2020Separate trading · Sharecare, Inc.
• 15 October 2020Exhibit 99.1  Gemini Therapeutics and FS Development Corp. Announce Merger Agreement Creating Publicly Listed Precision Medicine Company Focused on Age-Related Macular DegenerationDeal announced · Disc Medicine, Inc.
• 24 September 2020Exhibit 99.2 Falcon Capital Acquisition Corp. Announces Closing of $345 Million Initial Public OfferingIPO closing · Sharecare, Inc.
• 24 September 2020Exhibit 99.1 Falcon Capital Acquisition Corp. Announces Pricing of $300 Million Initial Public OfferingIPO pricing · Sharecare, Inc.
• 14 August 2020Exhibit 99.1 FS Development Corp., Sponsored by Foresite Capital, Announces Pricing of Upsized $105 Million Initial Public OfferingIPO pricing · Disc Medicine, Inc.